New Advances in Endometrial Ablation with Cerene Cryotherapy

On-Demand Webinar
HCP Resources Page
image
Description
This is a comprehensive webinar that dives into the challenges and advancements in treating heavy menstrual bleeding. Led by Dr. Barbara Levy and Dr. Gerard Riley, this session explores the impact of heavy menstrual bleeding on women's lives and reviews various treatment options, with a special focus on the latest advancement: the Cerene Cryotherapy Device. This webinar is a valuable resource for healthcare professionals seeking to enhance their understanding of endometrial ablation techniques and their implications for patient care.  

Key Takeaways
 
  1. Advancements in Endometrial Ablation with Cerene Cryotherapy: The webinar highlights the evolution of endometrial ablation, emphasizing the effectiveness of Cerene Cryotherapy. This method not only reduces bleeding but can also result in minimal intrauterine scarring. The speakers discuss the practical aspects of using Cerene, such as its ease of use in an office setting without the need for general anesthesia, and its high patient satisfaction rates.
  2. Patient-Centric Approach and Long-Term Outcomes: The discussion underscores the importance of aligning treatment with patient expectations and long-term health. It emphasizes the need for a thorough patient-provider discussion about potential risks and benefits, considering individual health circumstances. The speakers also touch upon the enduring effectiveness of Cerene Cryotherapy, evidenced by significant reductions in pain and bleeding over a three-year period.
  3. Case Studies and Practical Insights: The webinar provides real-world insights through case studies, illustrating the effectiveness of Cerene Cryotherapy in various scenarios. These examples highlight the versatility of the treatment and its ability to adapt to different patient needs, while helping maintain the integrity of the uterine cavity and minimizing the risk of complications.
Complete the Form Below to View
Now Playing
Video Library
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More